About Premedium Pharmaceuticals Private Limited
Data last updated:
Premedium Pharmaceuticals Private Limited is a private limited company based in Delhi, India, a subsidiary of Classic Industries And Exports Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24200DL2018PTC340319. Its GSTIN is 06AAKCP1334P1Z3 (Haryana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹21.79 Cr. It is led by directors including Dilip Birdi (Whole-Time Director) and Sanjiv Kumar Kothari.
Its last annual general meeting (AGM) was held on 27 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 14 Sector – 20 Dwarka, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.67 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Cr (net margin 15.4%) and EBITDA of ₹1.55 Cr (EBITDA margin 16%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years and 29% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Premedium Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹1 Cr on record. Court records list 37 cases involving the company, including 14 filed by the company and 23 filed against it; 8 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premediumpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 14 Sector – 20 Dwarka, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Premedium Pharmaceuticals Private Limited
The main business activity of Premedium Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Premedium Pharmaceuticals Private Limited FY 2025 filings available
Premedium Pharmaceuticals Private Limited reported revenue of ₹9.67 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Premedium Pharmaceuticals Private Limited
Revenue rose 29% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 29%. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Premedium Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.55 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.49 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Premedium Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 15.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Premedium Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ventus Pharmaceuticals Private Limited | ₹9.89 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Panchkula, Haryana, India |
| Carewin Pharmaceuticals (Gujarat) Private Limited | ₹9.77 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Ultravalue Pharmaceuticals Private Limited | ₹9.75 Cr (FY 2024) | •••• | •••• | 578.0% | •••• | Lucknow, Uttar Pradesh, India |
| Mcneil and Argus Pharmaceuticals Limited | ₹9.73 Cr (FY 2024) | •••• | •••• | -59.0% | •••• | Haryana, India |
| Shree Radhey Gobind International Pharmaceuticals Private Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Premedium Pharmaceuticals Private Limited this company | ₹9.67 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Delhi, India |
| Elicad Pharmaceuticals Private Limited | ₹9.66 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
| Ethiall Pharmaceuticals Private Limited | ₹9.64 Cr (FY 2025) | •••• | •••• | 305.0% | •••• | Bengaluru, Karnataka, India |
| Salvavita Pharmaceuticals Private Limited | ₹9.64 Cr (FY 2024) | •••• | •••• | 206290.0% | •••• | Ahmedabad, Gujarat, India |
| Willmark Pharmaceuticals Private Limited | ₹9.49 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Punjab, India |
| Yuvraj Pharmaceuticals Private Limited | ₹9.44 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Premedium Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals Private Limited is audited by S. C. V. & Co. LLP for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. C. V. & Co. LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjiv Kumar Kothari | Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Saras Malik | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
| Dilip Birdi | Whole-Time Director | 30 Dec 2019 | 6 Years 9 Months | Current |
Ownership and Shareholding of Premedium Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Premedium Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2019 | Others | ₹1 Cr | Satisfied |
Total charge records: 1 View all charges
Legal Cases of Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals Private Limited has 37 court cases on record: 14 filed by Premedium Pharmaceuticals, 23 filed against it. 8 cases are pending and 29 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 10 | 5 |
| High courts | 10 | 8 | 3 |
| NCLAT | 5 | 5 | 0 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CM(M)) | Filed by the company against Pure and Cure Healthcare Private Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Civil miscellaneous application | Filed by the company against Tirupati Medicare Limited | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Akums Drugs and Pharmaceuticals Limited | Pending |
| District court, Panchkula, Haryana | Civil miscellaneous application | Filed against the company by Beta Drugs Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Court case (Suit for Recovery) | Filed against the company by Tirupati Medicare Limited | Pending |
Full case history
All 37 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals operates one associated brand: Premedium Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical products for oncology, cardiology, and medical therapies. | premediumpharmaceuticals.com |
Employees and EPFO Compliance at Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals Private Limited has a workforce of 12 employees as of Mar 23, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals Private Limited has 9 board changes on record since 2018: 3 appointments and 6 cessations. The latest: Mohit Kumar Goel ceased to be Company Secretary on 07 Dec 2022.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Premedium Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Premedium Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Premedium Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCP1334P1Z3 | Haryana | Active | 13 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Premedium Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2018 (8+ years old) and is registered under CIN U24200DL2018PTC340319.
Premedium Pharmaceuticals reported revenue of ₹9.67 Cr for FY 2025 (up 29% YoY).
Premedium Pharmaceuticals has 3 current directors:
- Dilip Birdi - Whole-Time Director
- Sanjiv Kumar Kothari - Director
- Saras Malik - Director
Premedium Pharmaceuticals reported a net profit of ₹1.49 Cr (net margin 15.4%) and EBITDA of ₹1.55 Cr (EBITDA margin 16%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Premedium Pharmaceuticals is -39% over three years and -29% over five years. In the latest year (FY 2025) revenue rose 29%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Premedium Pharmaceuticals is 06AAKCP1334P1Z3, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Premedium Pharmaceuticals is U24200DL2018PTC340319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Premedium Pharmaceuticals has 37 court cases on record: 14 filed by the company and 23 filed against it. 8 are pending. Most are in the district courts.
Premedium Pharmaceuticals was incorporated on 09 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Premedium Pharmaceuticals by revenue are Ventus Pharmaceuticals Private Limited, Carewin Pharmaceuticals (Gujarat) Private Limited, Ultravalue Pharmaceuticals Private Limited, Mcneil and Argus Pharmaceuticals Limited, Shree Radhey Gobind International Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mohit Kumar Goel ceased to be Company Secretary on 07 Dec 2022. Rakesh Haldia ceased to be Cfo(Kmp) on 30 Jun 2022. Dilip Birdi was appointed as Whole-Time Director on 30 Dec 2019. Premedium Pharmaceuticals has 9 board changes on record in total.